Interpreting MYC and BCL2 in diffuse large B-cell lymphoma

被引：4
|
作者：
Lai, Catherine [1 ]
Grant, Cliona [1 ]
Dunleavy, Kieron [1 ]
机构：
[1] NCI, Ctr Canc Res, Bethesda, MD 20892 USA
来源：
LEUKEMIA & LYMPHOMA | 2013年 / 54卷 / 10期
关键词：
RITUXIMAB PLUS CYCLOPHOSPHAMIDE; POOR-PROGNOSIS; C-MYC; VINCRISTINE; DOXORUBICIN; PREDNISONE; EXPRESSION;
D O I：
10.3109/10428194.2013.806803
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2091 / 2092
页数：2
相关论文
共 50 条
  • [1] Diffuse Large B-Cell Lymphoma in Kenya: MYC, BCL2, and the Cell of Origin
    Wawire, Jonathan
    Sayed, Shahin
    Moloo, Zahir
    Sohani, Aliyah R.
    JOURNAL OF GLOBAL ONCOLOGY, 2019, 5 : 1 - 8
  • [2] Complex BCL2/IGH/MYC rearrangements in diffuse large B-cell lymphoma
    Sales, Mark
    Cunningham, J. J. P.
    Kernohan, N. M.
    Smith, G. D.
    Maliszewska, C. T.
    Pratt, N. R.
    JOURNAL OF MEDICAL GENETICS, 2007, 44 : S132 - S132
  • [3] BCL2 overexpression in diffuse large B-cell lymphoma
    Monni, O
    Franssila, K
    Joensuu, H
    Knuutila, S
    LEUKEMIA & LYMPHOMA, 1999, 34 (1-2) : 45 - 52
  • [4] BCL2 mutations in diffuse large B-cell lymphoma
    Schuetz, J. M.
    Johnson, N. A.
    Morin, R. D.
    Scott, D. W.
    Tan, K.
    Ben-Nierah, S.
    Boyle, M.
    Slack, G. W.
    Marra, M. A.
    Connors, J. M.
    Brooks-Wilson, A. R.
    Gascoyne, R. D.
    LEUKEMIA, 2012, 26 (06) : 1383 - 1390
  • [5] BCL2 MUTATIONS IN DIFFUSE LARGE B-CELL LYMPHOMA
    Schuetz, J.
    Johnson, N.
    Morin, R.
    Marra, M.
    Connors, J.
    Brooks-Wilson, A.
    Gascoyne, R.
    ANNALS OF ONCOLOGY, 2011, 22 : 207 - 207
  • [6] BCL2 mutations in diffuse large B-cell lymphoma
    J M Schuetz
    N A Johnson
    R D Morin
    D W Scott
    K Tan
    S Ben-Nierah
    M Boyle
    G W Slack
    M A Marra
    J M Connors
    A R Brooks-Wilson
    R D Gascoyne
    Leukemia, 2012, 26 : 1383 - 1390
  • [7] Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma
    Kramer, MHH
    Hermans, J
    Wijburg, E
    Philippo, K
    Geelen, E
    van Krieken, JHJM
    de Jong, D
    Maartense, E
    Schuuring, E
    Kluin, PM
    BLOOD, 1998, 92 (09) : 3152 - 3162
  • [8] Noninvasive Detection of BCL2, BCL6, and MYC Translocations in Diffuse Large B-Cell Lymphoma
    Kurtz, David M.
    Scherer, Florian
    Newman, Aaron M.
    Craig, Alexander
    Jin, Michael
    Stehr, Henning
    Chabon, Jacob J.
    Esfahani, Mohammad
    Liu, Chih Long
    Zhou, Li
    Glover, Cynthia
    Visser, Brendan C.
    Poultsides, George
    Advani, Ranjana H.
    Maeda, Lauren S.
    Gupta, Neel K.
    Levy, Ronald
    Ohgami, Robert S.
    Davis, R. Eric
    Kunder, Christian A.
    Westin, Jason R.
    Diehn, Maximilian
    Alizadeh, Ash A.
    BLOOD, 2016, 128 (22)
  • [9] High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology
    Scott, David W.
    King, Rebecca L.
    Staiger, Annette M.
    Ben-Neriah, Susana
    Jiang, Aixiang
    Horn, Heike
    Mottok, Anja
    Farinha, Pedro
    Slack, Graham W.
    Ennishi, Daisuke
    Schmitz, Norbert
    Pfreundschuh, Michael
    Nowakowski, Grzegorz S.
    Kahl, Brad S.
    Connors, Joseph M.
    Gascoyne, Randy D.
    Ott, German
    Macon, William R.
    Rosenwald, Andreas
    BLOOD, 2018, 131 (18) : 2060 - 2064
  • [10] BCL2 Is Highly Mutated In Diffuse Large B-Cell Lymphoma
    Schuetz, Johanna M.
    Johnson, Nathalie A.
    Morin, Ryan D.
    Hirst, Martin
    Zhao, Yongjun
    Tam, Angela
    Moore, Richard
    Zeng, Thomas
    Marra, Marco A.
    Connors, Joseph M.
    Brooks-Wilson, Angela R.
    Gascoyne, Randy D.
    BLOOD, 2010, 116 (21) : 1702 - 1703
12345